Status:
UNKNOWN
Pharmacological Optimization by a Specialized Outpatient Consultation Team
Lead Sponsor:
Fundacion Miguel Servet
Conditions:
Polypharmacy
Eligibility:
All Genders
75+ years
Brief Summary
Background Polypharmacy is a common condition among older adults and is a major issue of concern for its association with adverse drug reactions and adverse health outcomes, including falls, functiona...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- ≥ 75 years old
- Willing to provide informed consent
- Life expectancy ≥ 3 months
- Present polypharmacy (defined as ≥ 5 prescribed medications at the time of inclusion).
- Exclusion Criteria:
- Refusal to sign the informed consent form by the patient/primary caregiver/legal guardian or inability to obtain it.
- Participation in a clinical trial related to medication.
- In the event of a no-show or cancellation of the appointment at the first visit.
Exclusion
Key Trial Info
Start Date :
June 25 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT05408598
Start Date
June 25 2021
End Date
March 1 2023
Last Update
November 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Navarra (HUN)
Pamplona, Navarre, Spain, 31008